A Comparative Study of Food Intake and Adipose Tissue Distribution in Saudi Women with Polycystic Ovarian Syndrome

Overview

Journal Healthcare (Basel)

Specialty Health Services

Date 2024 Feb 10

PMID 38338254

Authors

Nujud H Hurayb

Ghedeir M Alshammari

Abdulrahman S Al-Khalifa

Nora Alafif

Dania H Aljaroudi

Mohammed A Mohammed

Abu ElGasim Ahmed Yagoub

Mohammed Abdo Yahya

Affiliations

Soon will be listed here.

Abstract

Polycystic ovary syndrome (PCOS) is a frequent disorder that affects reproductive-aged women and has reproductive, metabolic, and psychosocial effects. This research was intended to investigate the comparison between food intake and adipose tissue distribution in Saudi women suffering from PCOS and a control group. To determine the sociodemographic variables, a case-control study was performed with patients from King Fahad Medical City's Reproductive Endocrine and Infertility Medicine Department (REIMD). The case-control study comprised 42 PCOS patients (PCOS-Ps) and 63 as a control group, all aged 20-45 years. Three-day records were collected from participants to estimate the nutrient intake of cases and controls. A body composition analyzer was used to measure body mass index (BMI), body fat (BF), and visceral fat (VF). Biochemical measurements were taken to determine the lipid profile, total testosterone, and serum vitamin D-25-OH. The women's frequency distribution based on sociodemographic characteristics revealed significant differences within and between the groups. The variations in dietary intake between the PCOS-P and control groups were primarily in terms of total calories, carbohydrates, niacin, and folate, all of which were significantly higher in the PCOS-P group. Dietary fiber, unsaturated fat, vitamin A, vitamin B12, calcium, phosphorus, and selenium, on the other hand, were significantly higher in the control group. A majority of both groups had significantly higher BMI (overweight or obese) and higher BF, but normal VF. According to the findings, testosterone levels in PCOS-Ps were significantly higher than in the control group, but vitamin D-25-OH and high-density-lipoprotein cholesterol (HDL-C) were significantly lower. Age, monthly income, cholesterol, low-density-lipoprotein cholesterol (LDL-C), and testosterone were the fundamental causes impacting women's anthropometric indices. In conclusion, although both groups were overweight or obese, and differences in calorie and nutrient intake, HDL-C, testosterone, and vitamin D-25-OH levels were observed. The study advises such population groups to limit their consumption of foods high in calories.

References

Cutler D, Pride S, Cheung A . Low intakes of dietary fiber and magnesium are associated with insulin resistance and hyperandrogenism in polycystic ovary syndrome: A cohort study. Food Sci Nutr. 2019; 7(4):1426-1437. PMC: 6475723. DOI: 10.1002/fsn3.977. View

Costello M, Misso M, Balen A, Boyle J, Devoto L, Garad R . A brief update on the evidence supporting the treatment of infertility in polycystic ovary syndrome. Aust N Z J Obstet Gynaecol. 2019; 59(6):867-873. DOI: 10.1111/ajo.13051. View

Chien Y, Chang C, Wu M, Chen C, Horng Y, Wu H . Effects of Curcumin on Glycemic Control and Lipid Profile in Polycystic Ovary Syndrome: Systematic Review with Meta-Analysis and Trial Sequential Analysis. Nutrients. 2021; 13(2). PMC: 7924860. DOI: 10.3390/nu13020684. View

Kazemi M, Kim J, Parry S, Azziz R, Lujan M . Disparities in cardio metabolic risk between Black and White women with polycystic ovary syndrome: a systematic review and meta-analysis. Am J Obstet Gynecol. 2020; 224(5):428-444.e8. DOI: 10.1016/j.ajog.2020.12.019. View

Zhao L, Zhu Z, Lou H, Zhu G, Huang W, Zhang S . Polycystic ovary syndrome (PCOS) and the risk of coronary heart disease (CHD): a meta-analysis. Oncotarget. 2016; 7(23):33715-21. PMC: 5085114. DOI: 10.18632/oncotarget.9553. View

Awoke M, Earnest A, Joham A, Hodge A, Teede H, Brown W . Weight gain and lifestyle factors in women with and without polycystic ovary syndrome. Hum Reprod. 2021; 37(1):129-141. DOI: 10.1093/humrep/deab239. View

Macruz C, Lima S, Salles J, da Silva G, Scalissi N . Assessment of the body composition of patients with polycystic ovary syndrome using dual-energy X-ray absorptiometry. Int J Gynaecol Obstet. 2017; 136(3):285-289. DOI: 10.1002/ijgo.12066. View

Barber T, Franks S . Obesity and polycystic ovary syndrome. Clin Endocrinol (Oxf). 2021; 95(4):531-541. DOI: 10.1111/cen.14421. View

Fu L, Xie N, Qu F, Zhou J, Wang F . The Association Between Polycystic Ovary Syndrome and Metabolic Syndrome in Adolescents: a Systematic Review and Meta-analysis. Reprod Sci. 2022; 30(1):28-40. PMC: 9810687. DOI: 10.1007/s43032-022-00864-8. View

10.

Eslamian G, Baghestani A, Eghtesad S, Hekmatdoost A . Dietary carbohydrate composition is associated with polycystic ovary syndrome: a case-control study. J Hum Nutr Diet. 2016; 30(1):90-97. DOI: 10.1111/jhn.12388. View

11.

Kensara O . Prevalence of hypovitaminosis D, and its association with hypoadiponectinemia and hyperfollistatinemia, in Saudi women with naïve polycystic ovary syndrome. J Clin Transl Endocrinol. 2018; 12:20-25. PMC: 5992301. DOI: 10.1016/j.jcte.2018.04.001. View

12.

Dumesic D, Oberfield S, Stener-Victorin E, Marshall J, Laven J, Legro R . Scientific Statement on the Diagnostic Criteria, Epidemiology, Pathophysiology, and Molecular Genetics of Polycystic Ovary Syndrome. Endocr Rev. 2015; 36(5):487-525. PMC: 4591526. DOI: 10.1210/er.2015-1018. View

13.

Valdimarsdottir R, Wikstrom A, Kallak T, Elenis E, Axelsson O, Preissl H . Pregnancy outcome in women with polycystic ovary syndrome in relation to second-trimester testosterone levels. Reprod Biomed Online. 2020; 42(1):217-225. DOI: 10.1016/j.rbmo.2020.09.019. View

14.

Shang Y, Zhou H, He R, Lu W . Dietary Modification for Reproductive Health in Women With Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis. Front Endocrinol (Lausanne). 2021; 12:735954. PMC: 8591222. DOI: 10.3389/fendo.2021.735954. View

15.

Escobar-Morreale H . Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment. Nat Rev Endocrinol. 2018; 14(5):270-284. DOI: 10.1038/nrendo.2018.24. View

16.

Turner-Mcgrievy G, Davidson C, Billings D . Dietary intake, eating behaviors, and quality of life in women with polycystic ovary syndrome who are trying to conceive. Hum Fertil (Camb). 2014; 18(1):16-21. DOI: 10.3109/14647273.2014.922704. View

17.

Wang L, Lv S, Li F, Yu X, Bai E, Yang X . Vitamin D Deficiency Is Associated With Metabolic Risk Factors in Women With Polycystic Ovary Syndrome: A Cross-Sectional Study in Shaanxi China. Front Endocrinol (Lausanne). 2020; 11:171. PMC: 7136495. DOI: 10.3389/fendo.2020.00171. View

18.

Cooper A, Gupta S, Moustafa A, Chao A . Sex/Gender Differences in Obesity Prevalence, Comorbidities, and Treatment. Curr Obes Rep. 2021; 10(4):458-466. DOI: 10.1007/s13679-021-00453-x. View

19.

Lim S, Norman R, Clifton P, Noakes M . Hyperandrogenemia, psychological distress, and food cravings in young women. Physiol Behav. 2009; 98(3):276-80. DOI: 10.1016/j.physbeh.2009.05.020. View

20.

Duhil De Benaze G, Brauner R, Souberbielle J . There is no association between vitamin D status and characteristics of central precocious puberty in girls. Eur J Pediatr. 2017; 176(12):1677-1680. DOI: 10.1007/s00431-017-3022-9. View